Matthew P. Kosloski

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis

Evan S. Dellon, Marc E. Rothenberg, Margaret H. Collins et al. · New England Journal of Medicine · 2022 · 413 citations

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment

Edward Gane, Eric Lawitz, David Pugatch et al. · New England Journal of Medicine · 2017 · 394 citations · Full text

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried et al. · The Lancet · 2022 · 242 citations · Full text

Asthma, Uncontrolled Atopic Dermatitis, Atopic Dermatitis +4

A Phase <scp>II</scp> Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis

Roy Fleischmann, Henning Bliddal, Francisco J. Blanco et al. · Arthritis & Rheumatology · 2019 · 201 citations

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study

Jürgen K. Rockstroh, Karine Lacombe, Rolando M. Viani et al. · Clinical Infectious Diseases · 2018 · 144 citations · Full text